Award Year / Program / Phase:
2010 / STTR / Phase I
Agency:
HHS
Research Institution:
University Of Alabama System
DESCRIPTION (provided by applicant): Pancreatic islet transplantation is a viable approach for the treatment of type 1 diabetes (T1D). However, this therapeutic approach suffers from graft rejection. Dr. Shirwan, founder of ApoImmune, has developed a novel immunotherapeutic approach aimed at…
More